Immutep (IMMP) Long-Term Debt Repayments (2016 - 2023)

Immutep (IMMP) posted Long-Term Debt Repayments of $1.5 million for Q2 2023, up 1473.37% on a QoQ basis from $97746.3 in Q2 2016.

Immutep (IMMP) Long-Term Debt Repayments (2016 - 2023) Analysis & Trends

Immutep's Long-Term Debt Repayments history runs 2 years deep, the most recent figure standing at $1.5 million for Q2 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Long-Term Debt Repayments (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	7.64 Mn
4	NuCana	279.75 Bn	279.75 Bn	-	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	-
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	-
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	-
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	-
10	Immutep	567.77 Mn	567.77 Mn	-	-

Download Data